Open-label randomized controlled trial of ultra-low tidal ventilation without extracorporeal circulation in patients with COVID-19 pneumonia and moderate to severe ARDS: study protocol for the VT4COVID trial

BACKGROUND: Acute respiratory distress syndrome (ARDS) is a severe complication of COVID-19 pneumonia, with a mortality rate amounting to 34–50% in moderate and severe ARDS, and is associated with prolonged duration of invasive mechanical ventilation. Such as in non-COVID ARDS, harmful mechanical ve...

Descripción completa

Detalles Bibliográficos
Autores principales: Richard, Jean-Christophe, Yonis, Hodane, Bitker, Laurent, Roche, Sylvain, Wallet, Florent, Dupuis, Claire, Serrier, Hassan, Argaud, Laurent, Thiery, Guillaume, Delannoy, Bertrand, Pommier, Christian, Abraham, Paul, Muller, Michel, Aubrun, Frederic, Sigaud, Florian, Rigault, Guillaume, Joffredo, Emilie, Mezidi, Mehdi, Terzi, Nicolas, Rabilloud, Muriel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8503716/
https://www.ncbi.nlm.nih.gov/pubmed/34635128
http://dx.doi.org/10.1186/s13063-021-05665-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8503716/
https://www.ncbi.nlm.nih.gov/pubmed/34635128
http://dx.doi.org/10.1186/s13063-021-05665-z

Ejemplares similares